{"id":"W2054827450","doi":"10.1111/j.1464-410x.2006.06439.x","title":"Long‐term treatment with darifenacin for overactive bladder: results of a 2‐year, open‐label extension study","year":2006,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"Novartis Pharma; Astellas Pharma; Novartis","keywords":"Tolerability; Constipation; Overactive bladder; Medicine; Discontinuation; Adverse effect; Placebo; Urinary urgency; Defecation; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007958956,0.001290868,0.002811774,0.0004005003,0.0004303368,0.0008617525,0.0006866035,0.001438185,0.002118843],"category_scores_gemma":[0.003334827,0.0004944112,0.002131778,0.0003868245,0.0009115913,0.001477954,0.0004534735,0.002275737,0.000537678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004655009,"about_ca_system_score_gemma":0.0008235878,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004365649,"about_ca_topic_score_gemma":0.0005628697,"domain_scores_codex":[0.9982951,0.0009879181,0.0001387074,0.0001799176,0.0001959789,0.0002022904],"domain_scores_gemma":[0.995402,0.001359167,0.001066403,0.0005547332,0.0004099563,0.001207745],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8365027,0.06134073,0.01598274,0.0008231514,0.002130661,0.0002854565,0.0004347033,0.0007363887,0.01533856,0.00005918243,0.0008458034,0.06551991],"study_design_scores_gemma":[0.2140804,0.7286301,0.05239495,0.00006479889,0.001002269,0.0002384913,0.00007177181,0.000572292,0.001646334,0.00004878666,0.001202159,0.00004765279],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954358,0.002767077,0.0003661935,0.0001166072,0.00006382025,0.0004839921,0.0003989207,0.00002601533,0.0003414878],"genre_scores_gemma":[0.9946056,0.001355992,0.0007062895,0.0003953798,0.0002739218,0.0006699695,0.001200372,0.00001265476,0.000779799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007958956,"threshold_uncertainty_score":0.04209155,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04657458328816517,"score_gpt":0.3533337032661058,"score_spread":0.3067591199779406,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}